Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct 22;114(17):3578-87.
doi: 10.1182/blood-2009-03-213561. Epub 2009 Aug 21.

Microchimerism is strongly correlated with tolerance to noninherited maternal antigens in mice

Affiliations

Microchimerism is strongly correlated with tolerance to noninherited maternal antigens in mice

Partha Dutta et al. Blood. .

Abstract

In mice and humans, the immunologic effects of developmental exposure to noninherited maternal antigens (NIMAs) are quite variable. This heterogeneity likely reflects differences in the relative levels of NIMA-specific T regulatory (T(R)) versus T effector (T(E)) cells. We hypothesized that maintenance of NIMA-specific T(R) cells in the adult requires continuous exposure to maternal cells and antigens (eg, maternal microchimerism [MMc]). To test this idea, we used 2 sensitive quantitative polymerase chain reaction (qPCR) tests to detect MMc in different organs of NIMA(d)-exposed H2(b) mice. MMc was detected in 100% of neonates and a majority (61%) of adults; nursing by a NIMA+ mother was essential for preserving MMc into adulthood. MMc was most prevalent in heart, lungs, liver, and blood, but was rarely detected in unfractionated lymphoid tissues. However, MMc was detectable in isolated CD4+, CD11b+, and CD11c+ cell subsets of spleen, and in lineage-positive cells in heart. Suppression of delayed type hypersensitivity (DTH) and in vivo lymphoproliferation correlated with MMc levels, suggesting a link between T(R) and maternal cell engraftment. In the absence of neonatal exposure to NIMA via breastfeeding, MMc was lost, which was accompanied by sensitization to NIMA in some offspring, indicating a role of oral exposure in maintaining a favorable T(R) > T(E) balance.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Microchimerism in F1 backcross offspring. (A) The left panel shows a representative PCR curve showing standard and negative controls. The right panel shows H2Dd standard curve. Each data point is shown as mean ± range of values. qPCR was performed with BDF1 DNA diluted into B6 DNA in different concentrations. B6 DNA and blank (DNAase-free water) were used as negative controls. Primers and probe specific for maternal H2Dd were used to detect maternal DNA. A standard curve was made from 15 independent experiments. (B) Histogram showing variability in the levels of Mc in NIMAd-exposed versus control F1 backcross mice (standard breeding), plotted by percentage of offspring with indicated number of organs positive by H2Dd qPCR. (C) Top panel shows tissue distribution of Mc in different organs of NIMAd-exposed (n = 41 [*n = 12 for blood only]) and NIPAd (n = 16) control mice expressed as H2Dd gene equivalents (GEq) per 105 cells. The y-axis shows estimated GEq per 105 cells. Bottom panel shows GFP Mc in different organs of NIMAd NIMAGFP-exposed (n = 11) and NIPAd NIPAGFP control (n = 6) mice. (D) Summary of tissue distribution data in panel C expressed as a percentage of NIMA-exposed mice with detectable levels of Mc in each organ.
Figure 2
Figure 2
MMc in hematopoetic versus parenchymal cell lineages. (A) Cells from spleen and bone marrow of 6 NIMAd-exposed mice (standard breeding) were separated by expression of CD4, CD8, CD11b, and CD11c using MACS beads, and DNA was extracted from separated populations and tested for H2Dd MMc. The figure shows levels of MMc (GEq/105 sorted cells) in the sorted cell populations. Individual mice are represented by symbols as shown. (B) Cells of hematopoietic lineages (lineage+) and nonhematopoietic lineages (lineage) were sorted from single-cell suspensions of heart tissue pooled from 8 NIMAd-exposed mice. Lineage+ cells were sorted with a lineage cell depletion kit containing a cocktail of monoclonal antibodies against CD5, CD45R (B220), CD11b, Gr-1 (Ly-6G/C), 7-4, and Ter-119. Maternal cells were detected using H2Dd qPCR from the sorted fractions. The dots represent replicate values of analysis of the pooled lineage+ or lineage cell DNA sample.
Figure 3
Figure 3
Detection of NIMAd-specific TR cells using a DTH bystander suppression assay. Splenocytes were collected from NIMAd-exposed and NIPAd control offspring immunized with tetanus toxoid and diphtheria (TT/DT) vaccine 2 weeks previously. A total of 10 million splenocytes were injected into footpads of naive B6 recipients with coinjection inoculums: PBS, BDF1, or B6C3F1 Ag, or TT/DT. To measure bystander suppression, splenocytes were coinjected with BDF1Ag and TT/DT. Changes in footpad thickness were measured after 24 hours of injection to measure DTH reaction. (A) Examples of DTH bystander suppression assays. Spleen cells from 2 NIMAd-exposed mice (nos. 7 and 8) and 1 NIPAd control mouse (no. 1) that had been immunized with TT were coinjected into footpads with antigens shown on x-axis. Splenocytes from NIMAd no. 7 had a strong DTH response to TT but not to BDF1 antigen; the TT response was suppressed by 50% in the presence of BDF1 (maternal) Ag, but not in presence of third-party (B6C3F1) Ag. NIMAd no. 8 and the NIPAd control (no. 1) splenocytes did not suppress their strong anti-TT DTH responses in presence of the BDF1 Ag. (B) Summary of bystander suppression values in n = 54 mice. The horizontal lines represent mean values.
Figure 4
Figure 4
Correlation between the level of MMc and percentage of DTH inhibition. (A) Linear correlation between the percentage of DTH suppression and percentage of positive organs (out of a total of 8 or 9 organs tested per mouse) by qPCR. (B) NIMAd-exposed mice were divided into 2 groups on the basis of percentage of DTH suppression (50% and more and less than 50%) and plotted against the level (GEq/105 cells) of MMc. The y-axis shows average estimated GEq per 105 cells (average of 8 or 9 organs tested per mouse). (C) Percentage of DTH suppression plotted against levels of MMc averaged from 8 or 9 organs tested per mouse. The diagonal lines represent the best fit regression lines. Horizontal lines represent mean values.
Figure 5
Figure 5
“In vivo MLR” analysis of lymphocytes from NIMAd-exposed versus NIPAd control offspring. Splenocytes were harvested from NIMAd-exposed and NIPAd control mice and labeled with CFSE. CFSE-labeled splenocytes (50 × 106) were injected intravenously into a BDF1 recipient, which is the maternal type in the F1 backcross breeding system. After 3 days, splenocytes and ILN cells were harvested from the BDF1 recipients. (A) Flow cytometric analysis of lymphoproliferation in BDF1 hosts. H2Kd-negative CFSE-labeled splenic lymphocytes found in BDF1 ILNs were gated as shown. Total lymphocyte proliferation from MMc+ mouse NIMAd no. 9 was less than MMcneg NIMAd no. 10 and NIPA control (no. 2). (B) Inverse correlation between the level of MMc and percentage of proliferated responder lymphocytes recovered from BDF1 lymph nodes (n = 22). (C) Gating strategy for H2Kd-negative (donor) CD4+ T cells. (D) Surface TGF-β and (E) intracellular Foxp3 staining of donor CD4+ T cells. NIMAd no. 9–derived CD4+ T cells expressed a higher amount of surface TGF-β staining on nonproliferated CD4+ T cells than NIMAd no. 10 and NIPA control (no. 2). The horizontal line indicates the level of staining with isotype control antibody. (F) Correlation between the level of MMc and percentage of donor CD4+ T cells expressing surface TGF-β (n = 15). The diagonal lines represent the best fit regression lines in panels B and F.
Figure 6
Figure 6
Cells of NIMAd-exposed mice express low levels of maternal MHC class I antigen. Cells from thymus, spleen, pooled LNs, bone marrow, and blood of NIMAd-exposed and NIPAd control mice were stained with anti-H2Kd antibody and analyzed by flow cytometry. A minimum of 106 events were collected for each sample. All cells in the live gate (propidium iodide–excluding) were included in the analysis. (A) An example of flow histograms of H2Kd expression on peripheral blood mononuclear cells (PBMCs) from a NIMAd-exposed, NIPAd control, B6 negative control, and BDF1 positive control mouse. (B) Summary data of percentage of H2Kd-dim cells in various lymphoid organs of NIMAd-exposed mice (▵) and NIPAd control mice (●). B6 background values have been subtracted. The horizontal line indicates the lower limit of sensitivity by flow cytometry. (C) Example of levels of maternal H2Kd-dim offspring cells in blood at 4 different time points after weaning. (D) Comparison of peak percentages of maternal antigen-dim offspring cells (from 4 different time points tested) among 3 groups of offspring. The error bars represent SEM.
Figure 7
Figure 7
Oral exposure to maternal antigens is important in maintaining tolerance and preventing NIMA-induced sensitization. (A) Left panel shows average levels of MMc found in the heart, liver, and lungs in newborn offspring (less than 1 day old). Levels of MMc in heart, liver, and lungs of the newborn offspring are depicted in the right panel. (B) Newborn NIMAd-exposed mice were either nursed by the birth mother, or separated from their BDF1 mothers within 6 hours of birth and foster-nursed (F.N.) by B6 females. A control group of 3 NIMAd-exposed newborns were separated from their mothers and foster-nursed by another BDF1 female. Levels of H2Dd Mc (average of the organs tested) of the adult NIMAd-exposed mice (6-8 weeks old) nursed by their own mothers (NIMAd), or foster-nursed by B6 (F.N. by B6) or BDF1 mice (F.N. by BDF1) are shown. (C) Comparison of DTH responses to BDF1 antigens between NIMAd and NIMAd foster-nursed by B6. For a positive control response to BDF1 alloantigen, some NIPAd control mice were injected intravenously with BDF1 splenocytes 2 weeks before DTH assay and used as a source of sensitized splenocytes. The horizontal lines represent mean values of the observations.

References

    1. Carstens J, Andersen HK, Spencer E, Madsen M. Cytomegalovirus infection in renal transplant recipients. Transpl Infect Dis. 2006;8:203–212. - PubMed
    1. López MM, Valenzuela JE, Alvarez FC, Lopez-Alvarez MR, Cecilia GS, Paricio PP. Long-term problems related to immunosuppression. Transpl Immunol. 2006;17:31–35. - PubMed
    1. Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Saf. 2000;23:101–113. - PubMed
    1. Owen RD, Wood HR, Foord AG, Sturgeon P, Baldwin LG. Evidence for actively acquired tolerance to Rh antigens. Proc Natl Acad Sci U S A. 1954;40:420–424. - PMC - PubMed
    1. Burlingham WJ, Grailer AP, Heisey DM, et al. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med. 1998;339:1657–1664. - PubMed

Publication types

MeSH terms